A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency

NCT02247154 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Primary or Secondary Antibody Deficiency

Interventions

BIOLOGICAL: Vigam® (Human Normal Immunoglobulin)

Sponsor

Bio Products Laboratory